Background: Membrane trafficking of G protein-coupled receptors (GPCRs) is crucial for temporal and spatial control of cell-surface GPCR signaling. Receptor internalization is a well-documented method cells use for regulating a wide variety of GPCRs following their exposure to agonists. Results: We report that, upon agonist stimulation, a GPCR called vasoactive intestinal peptide receptor 2 (VPAC2) is shed, rather than being internalized, in vitro and in vivo, from the membrane of primary cilia-solitary hair-like organelles that project from the cell surface. VPAC2 is released into the extracellular milieu in the form of ciliary ectosomes that are devoid of exosome markers. The agonist-induced VPAC2 shedding is selective, as shown by the fact that other ciliary membrane proteins including two ciliary GPCRs are not shed with VPAC2. VPAC2 ectosome shedding is dependent on several components of endosomal sorting complexes required for transport (ESCRT), including a subset of ESCRT-III, VPS4, and LIP5. Agonist-stimulated VPAC2 is important for ciliary-ectosome generation because it allows VPS4 and LIP5 to transiently accumulate in primary cilia. Shedding of VPAC2 from the ciliary surface results in termination of intracellular VPAC2 signaling. Conclusions: Agonist-induced GPCR shedding from the ciliary surface may represent an additional mode of GPCR trafficking and signal regulation.
Introduction
G protein-coupled receptors (GPCRs) comprise a superfamily of seven transmembrane receptors that mediate a variety of cellular responses. Sustained stimulation by agonists induces the removal of many activated GPCRs from the cell surface. Reports over the past several decades have shaped our understanding of the molecular mechanisms underlying the removal of activated GPCRs from the cell surface, and clathrin-dependent endocytosis has been identified as one mechanism involved in this process [1, 2] .
Primary cilia are hair-like microtubule-based organelles that project out from the cell surface of many mammalian cells. They harbor membrane receptors, including several GPCRs, as well as their downstream signaling targets, and therefore function as signaling hubs [3, 4] . Although there is an emerging understanding of the cellular mechanisms that target GPCRs to cilia, little is known about whether ciliary GPCRs exit cilia and about the mechanisms and consequences of ciliary receptor exit.
Mammalian cells release small single-membrane vesicles; these include exosomes released by exocytosis of multivesicular bodies (MVBs) and ectosomes that bud directly from the plasma membrane [5, 6] . While there is no clear evidence that mammalian primary cilia shed ectosomes, Chlamydomonas flagella, which share structural and functional similarities with mammalian primary cilia, are known to shed ectosomes [7] , raising the possibility that mammalian primary cilia may do so as well.
Topologically similar membrane-sculpting processes, including MVB biogenesis, cytokinesis, and HIV egress, are mediated by the machinery of endosomal sorting complexes required for transport (ESCRT) complexes [8] [9] [10] [11] , which have recently been implicated in ectosome budding [12, 13] . ESCRT machinery consists of a series of distinct protein complexes (ESCRT-0, ESCRT-I, ESCRT-II, and ESCRT-III) and ESCRTassociated proteins, including Alix, an AAA-ATPase VPS4, and a VPS4 cofactor, LIP5; among them, ESCRT-III filaments play a central role in membrane fission, and the VPS4 complex facilitates this process [9, 10] .
By exploring the fate of agonist-stimulated ciliary GPCRs, we have found that the recently identified ciliary GPCR vasoactive intestinal peptide receptor 2 (VPAC2) [14] is selectively shed, both in vitro and in vivo, from suprachiasmatic nuclei (SCN) primary cilia upon specific agonist stimulation. VPAC2 is shed in the form of VPAC2-containing ectosomes that are devoid of exosome markers. VPAC2 shedding is dependent on several ESCRT components, including a subset of ESCRT-III (CHMP3, CHMP4B, and CHMP4C), VPS4, and a VPS4 cofactor, LIP5. Furthermore, agonist-stimulated VPAC2 is important for ciliary-ectosome generation because it allows VPS4 and LIP5 to transiently accumulate in primary cilia. Lastly, VPAC2 shedding results in the prolonged termination of its signaling. Together, these data demonstrate ectosome shedding from mammalian primary cilia, implicate a new mode of agonist-induced GPCR removal from the cell surface, and define an essential role of ESCRT-III and VPS4-LIP5 in the process of ciliary GPCR shedding.
Results

VPAC2 Is Removed from SCN Primary Cilia upon PACAP-27 Treatment In Vitro
We previously demonstrated that SCN and primary cultures prepared from SCN regions harbor VPAC2-positive primary cilia [14] . Under our culture conditions, w55% of rat SCN cells possessed primary cilia and w95% of those cilia were VPAC2-positive. In the course of determining the effect of ligand treatment on the ciliary localization of endogenous VPAC2, we found that a VPAC2 ligand, pituitary adenylate cyclaseactivating peptide 27 (PACAP-27), did not change the percentage of cells that possessed primary cilia; instead, it removed VPAC2 from SCN primary cilia in a dose-dependent manner, with the maximum effect occurring with 1 mM PACAP-27 (Figures 1A and 1B; Figure S1A available 
both VPAC2-LAP and Arl13B-mCherry to mark the primary cilium (the LAP tag consists of GFP followed by a cleavage site for a protease and an S tag [LAP tag: S tag-cleavage site-GFP]). Both proteins were localized to the cilium before PACAP-27 treatment and ligand treatment gradually removed VPAC2 from the cilium, leaving Arl13B unchanged ( Figure 1C) . By w26 min after the addition of 1 mM PACAP-27, we observed that VPAC2-LAP concentrated on particles that emerged from the cilium, gradually drifted away from cilia, and eventually disappeared from imaging fields (Figures 1C and 1D ; Movie S1). It is important to note that both 100 nM and 10 nM PACAP-27, while affecting fewer VPAC2-positive cilia, showed the same kinetics of VPAC2 shedding as 1 mM PACAP-27 treatment (Figure S1B ), suggesting that agonist-induced VPAC2 shedding occurs at physiological concentrations. The removal pattern observed in Figure 1C suggested that VPAC2 is disposed of into the extracellular space. Indeed, imaging of live SCN cells expressing VPAC2-LAP, with cytosolic mCherry marking the cell boundary, showed the scattered VPAC2 puncta located outside of the cell ( Figure 1E ). N-terminal LAP-tagged VPAC2 showed similar removal patterns ( Figure S1C ). We speculate that the one remaining VPAC2-positive signal was in fact a shed particle that became trapped near the ciliary base because it was not observed when cells were fixed and washed extensively for immunostaining ( Figure 1A ) and because it was always close to the cell ( Figures 1E and S1C ). Every VPAC2-positive punctum present outside of cells could be traced back to the cilium, suggesting that these puncta were coming strictly from the cilium.
Moreover, a newly developed anti-VPAC2 antibody detected endogenous VPAC2 in culture medium collected from PACAP-27-treated SCN cells, but not in culture medium collected from mock-treated cells ( Figure 1F ). Because exosomes are known to be released from primary neuron culture [15] , actin (enriched in exosomes [16] ) was used in this study as a control to ensure vesicle collections in both treatments. Taken together, these results show that VPAC2 is shed into the extracellular space upon PACAP-27 treatment in SCN in vitro.
These experiments also provided evidence that full-length endogenous VPAC2 was removed upon agonist treatment because the molecular weight of endogenous VPAC2 detected in the culture medium was indistinguishable from that of cell-associated VPAC2 ( Figure 1F ) and because both C-terminal-and N-terminal-tagged VPAC2 proteins showed similar removal patterns upon PACAP-27 treatment ( Figures  1E and S1C ).
PACAP-27 Shed VPAC2-Containing Ectosomes that Are Devoid of Exosome Markers
Live imaging of SCN cells expressing VPAC2-LAP stained with CellMask Orange, a plasma membrane dye that is slow to internalize, showed that all shed VPAC2-positive puncta were also positive for CellMask Orange, suggesting that VPAC2 is shed in a membrane-bound form ( Figure 2A and Movie S2).
In addition, when VPAC2-containing particles from 100,000 3 g centrifugation (P100) of PACAP-27-treated culture medium were resuspended, loaded on the bottom of an iodixanol gradient, and centrifuged at 100,000 3 g for 18 hr to equilibrium, VPAC2 was found floating in fractions 8-11, corresponding to densities of 1.104-1.154 g/ml ( Figure 2B ). These fractions were devoid of all three exosome markers tested: CD81 antigen (CD81), tumor susceptibility gene 101 (Tsg101), and ALG-2-interaction protein X (Alix) [17] ; they were found in fractions 4-5, corresponding to densities of 1.076-1.078 g/ml. Membranes and membrane-associated proteins float upward in the gradient to a lower density, while soluble or aggregated proteins remain at the bottom of the gradient.
Negative staining and electron microscopic analysis (Figure 2C) showed vesicles in the VPAC2-positive fractions (8-11 in Figure 2B ). In addition, immunogold labeling of VPAC2-positive fractions that were prepared from SCN culture transfected with LAP-VPAC2 by using anti-GFP antibody showed immunogold particles associated with vesicles ( Figures 2D and S2). Because size constraints likely make an MVB-based exosome pathway within cilia infeasible, we concluded that VPAC2 is shed in the form of VPAC2-containing ectosomes by outward budding from primary cilia membranes, analogous to the recent report of Chlamydomonas flagella bud ectosomes [7] .
PACAP-27-Induced VPAC2 Shedding from Ciliary Surface Is Highly Selective Because Arl13B, a ciliary protein, is not removed with VPAC2 ( Figure 1C ), we suspected that VPAC2 might be selectively shed from cilia. Indeed, we failed to detect IFT88, a component of cilia, and AC3, a ciliary membrane protein, in medium harvested from PACAP-27-treated SCN cells ( Figure 1F ). In addition, live imaging of SCN cells expressing GFP-tagged somatostatin receptor 3 (SSTR3-GFP) or SEP-tagged serotonin receptor 6 (SEP-5HT6) showed no release of these ciliary GPCRs over the entire hour of PACAP-27 treatment (Figures 3A and 3B), while VPAC2 ectosome shedding was evident by the release of CellMask Orange-positive vesicles. These data suggest that PACAP-27-induced VPAC2 removal from the ciliary surface is highly selective.
VPAC2 Is Shed into the Extracellular Milieu upon PACAP-27 Treatment In Vivo
PACAP-27-induced VPAC2 removal was also evident in vivo. We treated postnatal day 4 (P4) rat pups intranasally for 1 hr with PACAP-27, or with administration solution only, and determined its effects on VPAC2 ciliary localization by immunostaining SCN cryosections for endogenous VPAC2. Intranasal application has been used previously to deliver PACAP to rodents [18] [19] [20] and to humans [21] , and PACAP can be detected in the rat hypothalamus as early as 5-15 min after administration [20] . Interestingly, we found that after a single intranasal administration of PACAP-27, VPAC2 was removed from SCN primary cilia in a dose-dependent manner, with the maximum effect at 1 mg/animal ( Figures 4A and 4B ). Therefore, in vivo, exogenous PACAP-27 induces VPAC2 removal from SCN primary cilia. 
R E T R A C T E D
To test whether the removed VPAC2 was shed into the extracellular space in vivo, we intranasally administered P4 rat pups with PACAP-27 and harvested hypothalami containing the SCN region. Hypothalami were treated with papain to loosen the extracellular matrix and release extracellular materials into the solution, leaving cells intact; this procedure is widely used for harvesting viable cells from fresh brain tissues and has been recently used to harvest brain exosomes [22] . Harvested hypothalamic extracellular materials, which were loaded onto the bottom of an iodixanol gradient and centrifuged at 100,000 3 g for 18 hr to equilibrium, showed VPAC2-containing vesicles, devoid of exosome markers, in fractions 8-10. This corresponds to densities of 1.104-1.141 g/ml, similar to results from the primary SCN culture (Figure 4C, left) . VPAC2-containing ectosomes were not detected in P4 rat pups with intranasal mock treatment ( Figure 4C, right) . Taken together, these data demonstrate that exogenous PACAP-27 causes VPAC2 shedding into the extracellular milieu in the form of VPAC2-containing ectosomes in vivo.
PACAP is thought to be released from the retinohypothalamic tract (RHT) that innervates the SCN [23] . RHT projections appear in rat SCN from P1 but will not reach adult levels until P15 [24] . The concentration of endogenous PACAP-27 in P4 SCN might be too low to produce a measurable effect, which explains why we failed to detect VPAC2 ectosomes in P4 rat pups without exogenous PACAP-27 treatment ( Figures  4C, right, and 4D) . Consistent with the notion that RHT projections reach adult levels at P15, we detected VPAC2-containing ectosomes in extracellular materials harvested from P15 rat hypothalami without exogenous PACAP-27 treatment ( Figures  4D and 4E) .
A Subset of ESCRT-III, VPS4, and the VPS4 Cofactor, LIP5, Is Important for Agonist-Induced VPAC2 Ectosome Shedding Although not all ESCRT subunits are equally necessary for ESCRT-dependent processes, ESCRT-III and VPS4-LIP5 work together to catalyze membrane fission [10] and have been found to be always essential [25] . We therefore investigated the role of ESCRT-III, VPS4, and LIP5 in VPAC2 shedding.
While humans express 12 different ESCRT-III proteins (CHMP1A, CHMP1B, CHMP2A, CHMP2B, CHMP3, CHMP4A (not present in rodents), CHMP4B, CHMP4C, CHMP5, CHMP6, CHMP7, and IST1 [26] ), RT-PCR analysis showed that rat SCN cells do not express CHMP1B, CHMP2B, CHMP5, CHMP6, and CHMP7 ( Figure S3A ). Most of these ESCRT-III proteins were shown to act as dominant negative 
when C-terminally attached with a bulky tag [27, 28] . We expressed all LAP-tagged human ESCRT-III proteins in rat SCN cells and found that LAP-tagged hCHMP3, hCHMP4A, hCHMP4B, and hCHMP4C conferred significant dominantnegative effects on VPAC2 shedding ( Figure S3B ). Consistently, partial knockdown of these CHMPs partially inhibited VPAC2 shedding ( Figures 5A and S3C ). Mammals express two VPS4 proteins: VPS4A and VPS4B [29] . We found that expression of dominant-negative VPS4 mutant hVPS4A E228Q or hVPS4B E235Q [30] inhibited PACAP-27-induced VPAC2 shedding in rat SCN cells, while wild-type hVPS4A or hVPS4B did not ( Figure S3D ). Partial knockdown of VPS4 or the VPS4 cofactor, LIP5, partially inhibited VPAC2 shedding in rat SCN cells ( Figures 5B, 5C , and S3E). Neither expression of dominant-negative forms nor partial knockdown of these ESCRT proteins significantly affected ciliogenesis or cilia length (data not shown). Taken together, we conclude that a subset of ESCRT-III and VPS4-LIP5 is required for VPAC2 shedding.
While we did not detect VPS4-LAP and LIP5-LAP in SCN primary cilia before PACAP-27 treatment ( Figures 5D, 5E , and S3F), live imaging of rat SCN cells expressing hVPS4A-LAP and VPAC2-mCherry showed VPS4A puncta in cilia from w13 min after PACAP-27 treatment to just prior to VPAC2 shedding ( Figure 5D ). VPS4A puncta after w18 min were weaker in intensity and were more transient compared to VPS4 puncta between 13 and 18 min. VPS4B and LIP5 showed similar spatiotemporal patterns in cilia ( Figures S3F  and 5E ). Because no VPAC2 puncta were associated with VPS4A, VPS4B, or LIP5, we deduced that VPS4 and LIP5 are only transiently accumulated in cilia upon PACAP-27 treatment to facilitate VPAC2 shedding. Because LAP-tagged CHMPs act as dominant negative ( Figure S3B ), spatiotemporal patterns of CHMPs were not determined.
The Accumulation of VPS4 and LIP5 in Cilia upon PACAP-27 Treatment Is Dependent on VPAC2
To determine whether VPAC2 is important for ectosome shedding, we treated rat SCN cells with lentivirus-mediated rVPAC2 shRNAmiR that has been previously validated [14] : it reduces SCN cell VPAC2 mRNA levels to 4% of that of control shRNAmiR treatment and results in 0% VPAC2-positive cilia in SCN culture. Knockdown of VPAC2 ( Figure 6A ) completely abolished PACAP-27-induced shedding of ectosomes, as evident by lack of CellMask Orange particle release, suggesting that VPAC2 is required for PACAP-27-induced ciliaryectosome shedding.
Because VPS4 and LIP5 accumulated in cilia after PACAP-27 treatment and are required for VPAC2 ectosome shedding, we hypothesized that VPAC2 is important for VPS4 and LIP5 accumulation in cilia upon PACAP-27 treatment. Indeed, upon PACAP-27 treatment, no VPS4A was detectable in the cilia of cells pretreated with rVPAC2 shRNAmiR, while VPS4A accumulated in the cilia of cells pretreated with control shRNAmiR ( Figure 6B ). Knockdown of VPAC2 also abolished PACAP-27-induced VPS4B and LIP5 accumulation in cilia (Figures S4 and 6C) , suggesting that agonist-stimulated VPAC2 is involved in transient accumulation of VPS4-LIP5 in cilia to facilitate ciliary-ectosome shedding.
Agonist-Induced VPAC2 Shedding Leads to Long-Term Termination of Intracellular VPAC2 Signaling
Our findings raised the question of the functional consequences of VPAC2 shedding. We hypothesized that shedding of VPAC2 from the ciliary surface would temporarily terminate VPAC2-mediated signaling by removing active receptors from cilia until newly produced VPAC2 proteins could reinstate VPAC2 signaling capacity.
PACAP-27 binds to VPAC2 and to two of its homologs, VPAC1 and PAC1. In situ hybridization analyses have shown that rat SCN express VPAC2 and PAC1, but not VPAC1 [31, 32] . Using RT-PCR analysis, we confirmed the presence of PAC1 and VPAC2 and the absence of VPAC1 in our SCN cell cultures (data not shown). To determine the effect of VPAC2 shedding on VPAC2-specific intracellular signaling in SCN cells, we efficiently knocked down PAC1 using lentivirus-mediated rPAC1 shRNAmiR. Upon rPAC1 shRNAmiR treatment, the PAC1 mRNA level was reduced to 4% of that of control shRNAmiR treatment ( Figure 7A ) and PAC1 protein was not detectable in western blot ( Figure 7B To track VPAC2 signaling in these PAC1 knockdown SCN cells, we followed the fate of phosphorylation of extracellular signal-regulated kinase (p-ERK), the downstream signaling target of VPAC2 stimulation, after PACAP-27 treatment. Consistent with complete shedding of VPAC2 from treated cells by w40 min, p-ERK peaked at 10 min and then disappeared after 40 min of continuous PACAP-27 treatment (Figure 7C, left) . In contrast, PACAP-27 stimulation of VPS4 small hairpin RNA (shRNA)-treated cells (in which VPAC2 shedding was partially inhibited) caused the p-ERK to peak at 10 min and persist for 4 hr of continuous PACAP-27 treatment ( Figure 7C, right) . Thus, the disappearance of agoniststimulated VPAC2 signaling is caused by receptor shedding and not by PACAP-27 treatment directly.
Discussion
Until now, the prevailing mechanism known to remove activated GPCRs from the cell surface has been receptor endocytosis [1, 2] . Here, we demonstrate for the first time (D) VPAC2 was detected in extracellular materials harvested from hypothalami of P15 rats without exogenous PACAP-27 treatment. Hypothalami from P15 or P4 rat pups were removed and processed, and total lysate and extracellular materials (P100) were immunoblotted for VPAC2. (E) Hypothalami from P15 rats were removed and processed, and extracellular materials were loaded onto the bottom of an iodixanol gradient (5%-40%).
Fractions were collected from the top (1) to the bottom (14) of the tube following centrifugation. Fractions were blotted for VPAC2 and two exosomal markers, Tsg101 and Alix.
R E T R A C T E D
that upon PACAP-27 stimulation, the ciliary GPCR VPAC2 is shed from the SCN ciliary surface into the extracellular milieu in the form of ectosomes, in vitro and in vivo, resulting in termination of VPAC2-mediated intracellular signaling. Our results strongly suggest that agonist-induced GPCR shedding may represent another mode of GPCR surface removal for signaling regulation.
Our study clearly demonstrates that mammalian primary cilia shed ciliary ectosomes, and we begin to explain a mechanism whereby late-acting ESCRT proteins-including a subset of ESCRT-III, VPS4, and the VPS4 cofactor, LIP5-are involved in VPAC2 ectosome shedding. We show that PACAP-27 induces transient accumulation of VPS4 and LIP5 in cilia. Interestingly, ciliary-ectosome shedding does not occur until about 26 min after PACAP-27 treatment, despite the fact that VPS4 and LIP5 start to accumulate in cilia within about 13 min once the treatment is administered. This may indicate that VPS4 and LIP5 are important for remodeling 
ESCRT-III. We also show that PACAP-27-induced accumulation of VPS4 and LIP5 in cilia requires VPAC2. Because other ESCRT-dependent processes require early-acting ESCRT proteins (ESCRT-0, ESCRT-I, ESCRT-II, or Alix), we feel that it is unlikely that VPAC2 directly recruits VPS4-LIP5 to cilia. Systematic evaluation of the importance of other ESCRT proteins will help elucidate the exact mechanism of ciliaryectosome shedding. Although PACAP is known to be contained in the RHT that innervates the SCN via optic nerves and the optic tract [23] , the normal physiological response to endogenous PACAP and the normal conditions triggering the release of PACAP into SCN are not well established [33] . An exciting possibility is that VPAC2 shedding is a specific response to PACAP-27 in SCN. If proven to be true, our findings would provide a basis for further studies to help define when PACAP-27 is released and to illuminate its role in SCN. PACAP-27, by inducing VPAC2 shedding, may fine-tune VPAC2 signaling by controlling the number of receptors on cilia in vivo. Mice lacking VPAC2 [34] , or overexpressed with human VPAC2 [35] , exhibit altered circadian rhythms in locomotor behavior. In addition, duplication of the VPAC2 gene in humans confers significant risk of schizophrenia [36, 37] . As ectosomes shed from Chlamydomonas flagella have biological function [7] , PACAP-27, by releasing VPAC2-containing ciliary ectosomes, may also play a role in mediating intercellular signaling by transferring VPAC2 or other molecules to recipient cells.
Ectosome release is likely a general feature of mammalian primary cilia. It has been shown that neuroepithelial primary cilia might be a source for prominin-1-containing membranes 
found in neural tube fluid [38] and that exosome-like vesicles collected from urine are enriched in ciliary proteins [39] ; though in the latter case it has been suggested that these vesicles, rather than being shed, adhere to cilia. Other types of membrane release from mammalian cilia have also been reported. The rod outer segment, a specialized cilium of photoreceptors, has been shown to shed aged membranous discs at distal ends [40] . Cilia tips of retinal pigment epithelial cell lines expressing mutant CEP162 become strikingly swollen and release the bulging structures [41] . Further studies are required to determine whether these membrane releases are also dependent on ESCRT proteins. In summary, our study provides the first molecular and cellular insights into ESCRT-dependent, agonist-induced GPCR-containing ectosome shedding from mammalian primary cilia. Current studies are underway to determine the scope and extent of agonist-induced GPCR shedding (whether it is widespread or a relatively specific phenomenon) and to determine the in vivo consequences of its shedding.
Experimental Procedures
The complete details of the experimental procedures are provided in the Supplemental Experimental Procedures.
Animals
Rats were purchased from Charles Rivers. Animal care and use were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Laboratory Animal Care and Use Committee at the University of Illinois at Chicago.
Intranasal Administration
Intranasal administration was performed according to the procedure described previously [42] and was generally performed in the afternoon (w2:00 p.m.). In short, 0.25 mg, 0.5 mg, 0.75 mg, or 1 mg of PACAP-27 (American Peptide Company) was dissolved in 5 ml of water. The solution was administered intranasally to P4 rat pups (2.5 ml/nostril); 2.5 ml/nostril of water was administered as the control.
Vesicle Floatation on Iodixanol Gradient
To harvest vesicles from SCN cells, medium was harvested and centrifuged at 300 3 g for 10 min and 2,000 3 g for 30 min to remove intact and dead cells. The supernatant was spun at 15,000 3 g for 1 hr and 100,000 3 g for 1 hr (S110-AT fixed-angle rotor, Thermo Scientific). The pellet was washed with PBS and spun again at 100,000 3 g for 1 hr to obtain P100.
Vesicle harvest from the rat hypothalamus was performed as described previously [22] , with the following modifications. Hypothalami from rat pups were dissected, roughly chopped, and treated with papain (Worthington) at 37 C to loosen the extracellular matrix and to release extracellular materials in solution. Papain-treated hypothalami were disrupted with Dounce homogenizer, and homogenates were spun at 300 3 g for 10 min to remove cells. Supernatant was filtered through a 0.2 mm syringe filter. Filtrate was spun at 2,000 3 g for 30 min, 15,000 3 g for 1 hr, and 100,000 3 g for 1 hr. The pellet was washed with PBS and spun again at 100,000 3 g for 1 hr.
Discontinuous iodixanol gradient was prepared as described [43] . Briefly, solutions of 40%, 20%, 15%, 10%, 5%, and 0% iodixanol (w/v) were made by diluting a stock solution of OptiPrep (60% w/v) (Sigma) in 0.25 M sucrose/ 10 mM Tris (pH 7.5). P100 pellets from SCN culture or hypothalami were resuspended in 40% iodixanol (w/v) solution in 0.25 M sucrose/10 mM Tris (pH 7.5) and were layered with 20%, 15%, 10%, and 5% iodixanol solutions, followed by ultracentrifugation in S55S-1229 or S50-ST (Thermo Scientific) at 100,000 3 g for 18 hr at 4 C. The gradients were fractionated into 14 fractions of equal volume from the top. Fractions were analyzed immediately by standard SDS-PAGE and immunoblot analyses. 
